Literature DB >> 12374780

Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-alphaalpha and -alphabeta receptors.

Renhai Cao1, Ebba Bråkenhielm, Xuri Li, Kristian Pietras, Johan Widenfalk, Arne Ostman, Ulf Eriksson, Yuhai Cao.   

Abstract

A newly discovered PDGF isoform, PDGF-CC, is expressed in actively angiogenic tissues such as placenta, some embryonic tissues, and tumors. We test the possibility that PDGF-CC promotes angiogenesis in vivo. The core domain (mature form) of human PDGF-CC is sufficiently potent to stimulate neovascularization in the mouse cornea. The corneal angiogenic response induced by PDGF-CC is robust although the area of neovascularization is smaller than those of FGF-2- and VEGF-stimulated angiogenesis. Similarly, PDGF-BB and PDGF-AB induce angiogenic responses virtually indistinguishable from PDGF-CC-stimulated vessels. In contrast, PDGF-AA displays only a weak angiogenic response in the mouse cornea. Although there was no significant difference in incorporation of mural cells to the newly formed blood vessels induced by PDGF-BB and -CC, the percentage of mural cell positive vessels induced by PDGF-AA was greater than those induced by FGF-2, PDGF-BB, and PDGF-CC. In the developing chick embryo, PDGF-CC induced branch sprouts from established blood vessels. In PDGF receptor-transfected endothelial cells, PDGF-CC activated the PDGF receptor alpha subunit (PDGFR-alpha). PDGF-CC, but not PDGF-AA, was able to activate PDGFR-beta receptor in endothelial cells that coexpress both alpha and beta forms of receptors. Thus, the PDGF-CC-mediated angiogenic response is most likely transduced by PDGF-alphaalpha and -alphabeta receptors. These data demonstrate that the PDGF family is a complex and important group of proangiogenic factors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12374780     DOI: 10.1096/fj.02-0319com

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  63 in total

1.  PDGF-CC blockade inhibits pathological angiogenesis by acting on multiple cellular and molecular targets.

Authors:  Xu Hou; Anil Kumar; Chunsik Lee; Bin Wang; Pachiappan Arjunan; Lijin Dong; Arvydas Maminishkis; Zhongshu Tang; Yang Li; Fan Zhang; Shi-Zhuang Zhang; Piotr Wardega; Sagarika Chakrabarty; Baoying Liu; Zhijian Wu; Peter Colosi; Robert N Fariss; Johan Lennartsson; Robert Nussenblatt; J Silvio Gutkind; Yihai Cao; Xuri Li
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

Review 2.  Role of platelet-rich plasma in ischemic heart disease: An update on the latest evidence.

Authors:  Eleftherios Spartalis; Periklis Tomos; Demetrios Moris; Antonios Athanasiou; Charalampos Markakis; Michael D Spartalis; Theodore Troupis; Dimitrios Dimitroulis; Despina Perrea
Journal:  World J Cardiol       Date:  2015-10-26

3.  Over-expression of PDGF-C using a lung specific promoter results in abnormal lung development.

Authors:  Ying Zhuo; Gary W Hoyle; Bin Shan; Dawn R Levy; Joseph A Lasky
Journal:  Transgenic Res       Date:  2006-07-09       Impact factor: 2.788

4.  Combinatorial protein therapy of angiogenic and arteriogenic factors remarkably improves collaterogenesis and cardiac function in pigs.

Authors:  Huixia Lu; Xinsheng Xu; Mei Zhang; Renhai Cao; Ebba Bråkenhielm; Changjiang Li; Huili Lin; Guihua Yao; Huiwen Sun; Lihang Qi; Mengxiong Tang; Hongyan Dai; Yanen Zhang; Runyi Su; Yanwen Bi; Yun Zhang; Yihai Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-16       Impact factor: 11.205

5.  PDGF-C is a proinflammatory cytokine that mediates renal interstitial fibrosis.

Authors:  Frank Eitner; Eva Bücher; Claudia van Roeyen; Uta Kunter; Song Rong; Claudia Seikrit; Luigi Villa; Peter Boor; Linda Fredriksson; Gudrun Bäckström; Ulf Eriksson; Arne Ostman; Jürgen Floege; Tammo Ostendorf
Journal:  J Am Soc Nephrol       Date:  2008-01-09       Impact factor: 10.121

Review 6.  Fibroblast growth factor regulation of neovascularization.

Authors:  Masahiro Murakami; Michael Simons
Journal:  Curr Opin Hematol       Date:  2008-05       Impact factor: 3.284

Review 7.  New approaches in angiogenic targeting for colorectal cancer.

Authors:  Aleix Prat; Esther Casado; Javier Cortés
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

8.  Gadd45a suppresses tumor angiogenesis via inhibition of the mTOR/STAT3 protein pathway.

Authors:  Fang Yang; Weimin Zhang; Dan Li; Qimin Zhan
Journal:  J Biol Chem       Date:  2013-01-17       Impact factor: 5.157

9.  Annexin A2 is a molecular target for TM601, a peptide with tumor-targeting and anti-angiogenic effects.

Authors:  Kamala Kesavan; Judson Ratliff; Eric W Johnson; William Dahlberg; John M Asara; Preeti Misra; John V Frangioni; Douglas B Jacoby
Journal:  J Biol Chem       Date:  2009-12-15       Impact factor: 5.157

10.  Haemangiopericytoma of the thyroid gland in combination with Hashimoto's disease.

Authors:  T Hansen; A Gaumann; M Ghalibafian; A Höferlin; A Heintz; C J Kirkpatrick
Journal:  Virchows Arch       Date:  2004-07-09       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.